Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Instagram Outage Disrupts Thousands of U.S. Users 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Dublin, Jan. 08, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/fgjml9/neurostimulation) has announced the addition of the "Neurostimulation - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
This report analyzes the worldwide markets for Neurostimulation in US$ by the following Product Segments: Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES).
The United States is analyzed both in terms of value (US$) and volume (units) sales.
The report profiles 30 companies including many key and niche players such as
- Aleva Neurotherapeutics SA (Switzerland)
- BioControl Medical (Israel)
- Bioness Inc. (USA)
- Boston Scientific Corp. (USA)
- EnteroMedics Inc. (USA)
- LivaNova PLC (UK)
- Medtronic, Inc. (USA)
- NeuroPace, Inc. (USA)
- NeuroSigma, Inc. (USA)
- Nevro Corp. (USA)
- SPR Therapeutics, LLC (US)
- St. Jude Medical, Inc. (USA)
- Synapse Biomedical, Inc. (USA)
Key Topics Covered:
1. MARKET OVERVIEW
2. COMPETITIVE SCENARIO
3. GROWTH DRIVERS, TRENDS, & ISSUES
4. MACRO GROWTH DRIVERS FOR NEUROSTIMULATION INDUSTRY
5. TECHNOLOGICAL ADVANCEMENTS IN NEUROSTIMULATION MARKET
6. SELECT TARGETED INDICATIONS
7. PRODUCT OVERVIEW
8. NEUROSTIMULATION DEVICE APPROVALS
9. PRODUCT INNOVATIONS/INTRODUCTIONS
10. RECENT INDUSTRY ACTIVITY
11. FOCUS ON SELECT PLAYERS
12. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 30 (including Divisions/Subsidiaries - 31)
- The United States (23)
- Europe (7)
- - Germany (2)
- - The United Kingdom (2)
- - Rest of Europe (3)
- Middle East (1)
For more information visit http://www.researchandmarkets.com/research/fgjml9/neurostimulation
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Devices, Neurology Devices
